the staff's "dearth of knowledge" about the correct procedure to follow when someone dies unexpectedly was also highlighted.
.
.
despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.
.
.